Intra-arterial administration of cell-based biological agents for ischemic stroke therapy

References

• Craig AJ, Housley GD. Evaluation of gene therapy as an intervention strategy to treat brain injury from stroke. Front Mol Neurosci. 2016;24(9):34.
   Google Scholar
• de Los Ríos la Rosa F, Khoury J, Kissela BM, et al. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the european cooperative acute stroke study (ECASS) III trial. Stroke. 2012;43(6):1591–1595.
   PubMed Web of Science ®Google Scholar
• Madsen TE, Khoury JC, Alwell KA, et al. Analysis of tissue plasminogen activator eligibility by sex in the Greater Cincinnati/Northern Kentucky stroke study. Stroke. 2015;46(3):717–721.
   PubMed Web of Science ®Google Scholar
• Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 29;384(9958):1929–1935.
   PubMed Web of Science ®Google Scholar
• Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285–2295.
   PubMed Web of Science ®Google Scholar
• Bliss T, Guzman R, Daadi M, et al. Cell transplantation therapy for stroke. Stroke. 2007;38:817–826.
   PubMed Web of Science ®Google Scholar
• Rhim T, Lee M. Targeted delivery of growth factors in ischemic stroke animal models. Expert Opin Drug Deliv. 2016;13(5):709–723.
   PubMed Web of Science ®Google Scholar
• Yanamoto H, Nagata I, Niitsu Y, et al. Evaluation of MCAO stroke models in normotensive rats: standardized neocortical infarction by the 3VO technique. Exp Neurol. 2003;182(2):261–274.
   PubMed Web of Science ®Google Scholar
• Drury-Stewart D, Song M, Mohamad O, et al. Highly efficient differentiation of neural precursors from human embryonic stem cells and benefits of transplantation after ischemic stroke in mice. Stem Cell Res Ther. 2013;4:93.
   PubMed Web of Science ®Google Scholar
• Mohamad O, Drury-Stewart D, Song M, et al. Vector-free and transgene-free human iPS cells differentiate into functional neurons and enhance functional recovery after ischemic stroke in mice. PLoS ONE. 2013;8(5):e64160.
   PubMed Web of Science ®Google Scholar
• Yuan T, Liao W, Feng NH, et al. Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion. Stem Cell Res Ther. 2013;4(3):73.
   PubMedGoogle Scholar
• He B, Yao Q, Liang Z, et al. The dose of intravenously transplanted bone marrow stromal cells determines the therapeutic effect on vascular remodeling in a rat model of ischemic stroke. Cell Transplant. 2016;25:2173–2185.
   PubMed Web of Science ®Google Scholar
• Lim J, Jeong C, Jun J, et al. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther. 2011;2(5):38.
   PubMedGoogle Scholar
• Zhu J, Liu Q, Jiang Y, et al. Enhanced angiogenesis promoted by human umbilical mesenchymal stem cell transplantation in stroked mouse is Notch1 signaling associated. Neuroscience. 2015;290:288–299.
   PubMed Web of Science ®Google Scholar
• Nomura T, Honmou O, Harada K, et al. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience. 2005;136(1):161–169.
   PubMed Web of Science ®Google Scholar
• Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain. 2006;129:2734–2745.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhu HB, Liao J, et al. Regulation of naotai recipe on the expression of HIF-lα/VEGF signaling pathway in cerebral ischemia/reperfusion rats. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014;34(10):1225–1230.
   PubMedGoogle Scholar
• Rosell A, Cuadrado E, Ortega-Aznar A, et al. MMP-9 positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008;39:1121–1126.
   PubMed Web of Science ®Google Scholar
• Labrie M, St-Pierre Y. Epigenetic regulation of mmp-9 gene expression. Cell Mol Life Sci. 2013;70:3109–3124.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Kuo CD, Chen SH, et al. Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells. PLoS One. 2012;7(5):e37006.
   PubMed Web of Science ®Google Scholar
• Hacke W. A new dawn for imaging-based selection in the treatment of acute stroke. N Engl J Med. 2018;378(1):81–83.
   PubMed Web of Science ®Google Scholar
• Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000;20:1276–1293.
   PubMed Web of Science ®Google Scholar
• Misra V, Ritchie MM, Stone LL, et al. Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology. 2012;79(13 suppl 1):S207–S212.
   PubMed Web of Science ®Google Scholar
• Lemmens R, Stenberg G. Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol. 2013 Dec;26(6):617–625.
   PubMed Web of Science ®Google Scholar
• Guzman R, Janowski M, Walczak P. Intra-arterial delivery of cell therapies for stroke. Stroke. 2018;49(5):1075–1082.
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 2004;16(1):1–13.
   PubMed Web of Science ®Google Scholar
• Khan IS, Odom M, Ehtesham M, et al. Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities. J Neurosurg. 2016;125(1):152–159.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Houck K, Jakeman L, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr.Rev. 1992;13(1):18–32.
   PubMed Web of Science ®Google Scholar
• Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci. 1999;19(14):5731–5740.
   PubMed Web of Science ®Google Scholar
• Islamov RR, Chintalgattu V, Pak ES, et al. Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury. Neuroreport. 2004;15(13):2117–2121.
   PubMed Web of Science ®Google Scholar
• Jin L, Ne T, Blau CA. Marrow sensitization to 5-fluorouracil using the ligands for Flt-3 and c-Kit. Exp Hematol 1999;27(3):520–525.
   PubMed Web of Science ®Google Scholar
• Rosenstein JM, Mani N, Silverman WF, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA. 1998;95(12):7086–7091.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wu JP, Tzeng SF. Neuroprotection of glial cell line derived neurotrophic factor in damaged spinal cords following contusive injury. J Neurosci Res. 2002;69(3):397–405.
   PubMed Web of Science ®Google Scholar
• Iannotti C, Li H, Yan P, et al. Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp Neurol. 2003;183(2):379–393.
   PubMed Web of Science ®Google Scholar
• Karlupia N, Manley NC, Prasad K, et al. Intra-arterial transplantation of human umbilical cord blood mononuclearcells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model. Stem Cell Res Ther. 2014;5(2):45.
   PubMedGoogle Scholar
• Jeong H, Yim HW, Cho Y, et al. Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis. Int J Stem Cells. 2014;7(2):63–69.
   PubMedGoogle Scholar
• Wang XL, Zhao YS, Hu MY, et al. Umbilical cord blood cells regulate endogenous neural stem cell proliferation via hedgehog signaling in hypoxic ischemic neonatal rats. Brain Res. 2013;1518:26–35.
   PubMed Web of Science ®Google Scholar
• Chernykh ER, Shevela EY, Starostina NM, et al. Safety and therapeutic potential of M2 macrophages in stroke treatment. CellTransplant. 2016;25(8):1461–1471.
   Web of Science ®Google Scholar
• Islamov RR, Izmailov AA, Sokolov ME, et al. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats. Brain Res Bull. 2017;132:44–52.
   PubMed Web of Science ®Google Scholar
• Islamov RR, Rizvanov AA, Fedotova VY, et al. Tandem delivery of multiple therapeutic genes using umbilical cord blood cells improves symptomatic outcomes in ALS. Mol Neurobiol. 2017;54(6):4756–4763.
   PubMed Web of Science ®Google Scholar
• Yang WZ, Zhang Y, Wu F, et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med. 2010;8:75.
   PubMed Web of Science ®Google Scholar
• Ballen KK, Gluckman E, Broxmeyer HE. Umbilical cord blood transplantation: the first 25 years and beyond. Blood. 2013;122(4):491–498.
   PubMed Web of Science ®Google Scholar
• Weise G, Lorenz M, Pösel C, et al. Transplantation of cryopreserved human umbilical cord blood mononuclear cells does not induce sustained recovery after experimental stroke in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2014;34:182–184.
   Web of Science ®Google Scholar
• Boltze J, Reich DM, Hau S, et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant. 2012;21(4):723–737.
   PubMed Web of Science ®Google Scholar
• Chen J, Sanberg PR, Li Y, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 2001;32:2682–2688.
   PubMedGoogle Scholar
• Sokolov ME, Bashirov FV, Markosyan VA, et al. Triple-gene therapy for stroke: a proof-of-concept in vivo study in rats front. Pharmacol. 2018;9:111.
   Web of Science ®Google Scholar
• Czabotar PE, Lessene G, Strasser A, et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014;15(1):49–63.
   PubMed Web of Science ®Google Scholar
• Zhong LT, Sarafian T, Kane DJ, et al. Bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA. 1993;90(10):4533–4537.
   PubMed Web of Science ®Google Scholar
• Murphy AN, Fiskum G. Bcl-2 and Ca(2+)-mediated mitochondrial dysfunction in neural cell death. Biochem Soc Symp. 1999;66:33–41.
   PubMedGoogle Scholar
• Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262(5137):1274–1277.
   PubMed Web of Science ®Google Scholar
• Zhao H, Yenari M, Cheng D, et al. Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab. 2004;24(6):681–692.
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Matsumoto M, Tsujimoto Y, et al. Amelioration of hippocampal neuronal damage after global ischemia by neuronal overexpression of BCL-2 in transgenic mice. Stroke. 1998;29(12):2616–2621.
   PubMed Web of Science ®Google Scholar
• Lei ZN, Liu F, Zhang LM, et al. Bcl-2 increases stroke-induced striatal neurogenesis in adult brains by inhibiting BMP-4 function via activation of beta-catenin signaling. Neurochem Int. 2012;61(1):34–42.
   PubMed Web of Science ®Google Scholar
• van der Weerd L, Tariq Akbar M, Aron Badin R, et al. Overexpression of heat shock protein 27 reduces cortical damage after cerebral ischemia. J Cereb Blood Flow Metab. 2010;30(4):849–856.
   PubMed Web of Science ®Google Scholar
• Yenari MA, Fink SL, Sun GH, et al. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann.Neurol. 1998;44(4):584–591.
   PubMed Web of Science ®Google Scholar
• Hoehn B, Ringer TM, Xu L, et al. Overexpression of HSP72 after induction of experimental stroke protects neurons from ischemic damage. J Cereb Blood Flow Metab. 2001;21(11):1303–1309.
   PubMed Web of Science ®Google Scholar
• Kelly S, Zhang ZJ, Zhao H, et al. Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol. 2002;52(2):160–167.
   PubMed Web of Science ®Google Scholar
• Badin RA, Lythgoe MF, van der Weerd L, et al. Neuroprotective effects of virally delivered HSPs in experimental stroke. J Cereb Blood Flow Metab. 2006;26(3):371–381.
   PubMed Web of Science ®Google Scholar
• Badin RA, Modo M, Cheetham M, et al. Protective eect of post-ischaemic viral delivery of heat shock proteins in vivo. J Cereb Blood Flow Metab. 2009;29(2):254–263.
   PubMed Web of Science ®Google Scholar
• Lawrence MS, McLaughlin JR, Sun GH, et al. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J Cereb Blood Flow Metab. 1997;17(7):740–744.
   PubMed Web of Science ®Google Scholar
• Otsuka S, Sakakima H, Sumizono M, et al. The neuroprotective effects of preconditioning exercise on brain damage and neurotrophic factors after focal brain ischemia in rats. Behav Brain Res. 2016;303:9–18.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Pardridge WM. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system. Stroke. 2001;32(6):1378–1384.
   PubMed Web of Science ®Google Scholar
• Yuan M, Wen S, Yang C, et al. Transplantation of neural stem cells overexpressing glial cell line-derived neurotrophic factor enhances Akt and Erk1/2 signaling and neurogenesis in rats after stroke.Chin. Med J. 2013;126(7):1302–1309.
   Google Scholar
• Semkova I, Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Rev. 1999;30(2):176–188.
   PubMedGoogle Scholar
• Tabakman R, Jiang H, Shahar I, et al. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression. Ann NY Acad Sci. 2005;1053:84–96.
   PubMedGoogle Scholar
• Andsberg G, Kokaia Z, Klein RL, et al. Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats. Neurobiol Dis. 2002;9(2):187–204.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu Z, Yu Z, et al. rAAV-mediated delivery of brain-derived neurotrophic factor promotes neurite outgrowth and protects neurodegeneration in focal ischemic model. Int J Clin Exp Pathol. 2011;4(5):496–504.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Chen SL, Chiang YH, et al. Recombinant adeno-associated virus vector expressing glial cell linederived neurotrophic factor reduces ischemia-induced damage. Exp Neurol. 2000;166(2):266–275.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Chen SL, Xiao X, et al. Gene therapy of focal cerebral ischemia using defective recombinant adeno-associated virus vectors. Front Biosci. 2006;11:2061–2070.
   PubMed Web of Science ®Google Scholar
• Hermann DM, Kilic E, Kugler S, et al. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis. 2001;8(4):655–666.
   PubMed Web of Science ®Google Scholar
• Zhang WR, Sato K, Iwai M, et al. Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res. 2002;947(1):140–145.
   PubMed Web of Science ®Google Scholar
• Harvey BK, Chang CF, Chiang YH, et al. HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. Exp Neurol. 2003;183(1):47–55.
   PubMed Web of Science ®Google Scholar
• Wong LF, Ralph GS, Walmsley LE, et al. Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Mol Ther. 2005;11(1):89–95.
   PubMed Web of Science ®Google Scholar
• Matlik K, Abo-Ramadan U, Harvey BK, et al. AAV-mediated targeting of gene expression to the peri-infarct region in rat cortical stroke model. J Neurosci Methods. 2014 30;236:107–113.
   PubMed Web of Science ®Google Scholar
• Boltze J., Arnold A, Walczak P, et al. The dark side of the force – constraints and complications of cell therapies for stroke. Front Neurol. 2015;6:155.
   PubMed Web of Science ®Google Scholar
• Murakami K, Kondo T, Epstein CJ, et al. Overexpression of CuZn-Superoxide dismutase reduces hippocampal injury after global ischemia in transgenic mice. Stroke. 1997;28(9):1797–1804.
   PubMed Web of Science ®Google Scholar
• Chan PH, Kawase M, Murakami K, et al. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J Neurosci. 1998;18(20):8292–8299.
   PubMed Web of Science ®Google Scholar
• Kawase M, Murakami K, Fujimura M, et al. Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke. 1999;30(9):1962–1968.
   PubMed Web of Science ®Google Scholar
• Moretti A, Ferrari F, Villa RF. Neuroprotection for ischemic stroke: current status and challenges. Pharmacol Ther. 2015;146:23–34.
   PubMed Web of Science ®Google Scholar
• García-Berrocoso T, Giralt D, Llombart V, et al. Chemokines after human ischemic stroke: from neurovascular unit to blood using protein arrays. Transl Proteom. 2014;3:1–9.
   Google Scholar
• Wang Y, Huang J, Li Y, et al. Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr Drug Targets. 2012;13(2):166–172.
   PubMed Web of Science ®Google Scholar
• Ruscher K, Kuric E, Liu Y, et al. Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke. J Cereb Blood Flow Metab. 2013;33(8):1225–1234.
   PubMed Web of Science ®Google Scholar
• Tsai TH, Chen SL, Xiao X, et al. Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model. Neuroreport. 2003;14(6):803–807.
   PubMed Web of Science ®Google Scholar
• Bowen KK, Dempsey RJ, Vemuganti R. Adult interleukin-6 knockout mice show compromised neurogenesis. Neuroreport. 2011;22(3):126–130.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Perez O, Gutierrez-Fernandez F, Lopez-Virgen V, et al. Immunological regulation of neurogenic niches in the adult brain. Neuroscience. 2012;226(8):270–281.
   PubMedGoogle Scholar
• Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1–2):53–68.
   PubMed Web of Science ®Google Scholar
• Mennicken F, Maki R, de Souza EB, et al. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci. 1999;20(2):73–78.
   PubMed Web of Science ®Google Scholar
• Bajetto A, Bonavia R, Barbero S, et al. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol. 2001;22(3):147–184.
   PubMed Web of Science ®Google Scholar
• Janowski M, Lyczek A, Engels C, et al. Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab. 2013;33:921–927.
   PubMed Web of Science ®Google Scholar
• Cui LL, Kerkelä E, Bakreen A, et al. The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity. Stem Cell Res Ther. 2015;6:11.
   PubMed Web of Science ®Google Scholar
• Cui LL, Nitzsche F, Pryazhnikov E, et al. Integrin α4 overexpression on rat mesenchymal stem cells enhances transmigration and reduces cerebral embolism after intracarotid injection. Stroke. 2017 Oct;48(10):2895–2900.
   PubMed Web of Science ®Google Scholar
• Da Fonseca LMB, Gutfilen B, Rosado de Castro PH, et al. Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp Neurol. 2010;221:122–128.
   PubMed Web of Science ®Google Scholar
• Rosadode-Castro P-H, Schmidt FR, Battistella V, et al. Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regener Med. 2013;8(2):145–155.
   PubMed Web of Science ®Google Scholar
• Barbosa Da Fonseca LM, Battistella V, de Freitas GR, et al. Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation. 2009;120(6):539–541.
   PubMed Web of Science ®Google Scholar
• Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67(2):181–198.
   PubMed Web of Science ®Google Scholar
• Campbell BC, Mitchell PJ. EXTEND-IA investigators. Endovascular therapy for ischemic stroke. N Engl J Med. 2015;372(24):2365–2366.
   PubMed Web of Science ®Google Scholar
• Nogueira RG, Jadhav AP, Haussen DC, et al. DAWN trial investigators. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11–21.
   PubMed Web of Science ®Google Scholar
• van Overhagen H, van Zwam WH, Krajina A, et al. CIRSE Position statement: interventional radiologists and intra-arterial stroke therapy. Cardiovasc Intervent Radiol. 2018;41(10):1460–1462.
   PubMed Web of Science ®Google Scholar